These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38465812)

  • 1. [Multi-center open comparative randomized study of efficacy and safety of Akatinol Memantine 20 mg (single-doses) vs Akatinol Memantine 10 mg (double-doses) in patients with vascular dementia].
    Gavrilova SI; Kolykhalov IV; Mikhaylova NM; Ponomareva EV; Fedorova YB; Medvedev VE; Frolova VI; Gushanskaya EV; Litvinenko IV; Emelin AY; Lobzin VY; Kashin AV; Tanashyan MM; Kachanova MV; Knyazev AV; Gonik MI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(2):69-77. PubMed ID: 38465812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical efficacy and safety of akatinol memantine in treatment of mild to moderate Alzheimer disease: a donepezil-controlled, randomized trial].
    Hu HT; Zhang ZX; Yao JL; Yu HZ; Wang YH; Tang HC; Ji CJ; Xu T
    Zhonghua Nei Ke Za Zhi; 2006 Apr; 45(4):277-80. PubMed ID: 16780671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclandelate in the treatment of patients with mild to moderate primary degenerative dementia of the Alzheimer type or vascular dementia: experience from a placebo controlled multi-center study.
    Weyer G; Eul A; Milde K; Wierich W; Herrmann WM
    Pharmacopsychiatry; 2000 May; 33(3):89-97. PubMed ID: 10855459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Memantine for dementia.
    McShane R; Westby MJ; Roberts E; Minakaran N; Schneider L; Farrimond LE; Maayan N; Ware J; Debarros J
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD003154. PubMed ID: 30891742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Memantine for dementia.
    Areosa SA; Sherriff F
    Cochrane Database Syst Rev; 2003; (3):CD003154. PubMed ID: 12917950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy, safety and tolerability of a single dose of akatinol memantine in comparison to two-doses in patients with moderately expressed and moderately severe dementia in Alzheimer's disease].
    Kolykhalov IV; Gavrilova SI; Kalyn IaB; Selezneva ND; Fedorova IaB
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(1):35-9. PubMed ID: 22678673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of memantine in patients with mild to moderate vascular dementia: a randomized, placebo-controlled trial (MMM 300).
    Orgogozo JM; Rigaud AS; Stöffler A; Möbius HJ; Forette F
    Stroke; 2002 Jul; 33(7):1834-9. PubMed ID: 12105362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500).
    Wilcock G; Möbius HJ; Stöffler A;
    Int Clin Psychopharmacol; 2002 Nov; 17(6):297-305. PubMed ID: 12409683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial.
    De Jesus Moreno Moreno M
    Clin Ther; 2003 Jan; 25(1):178-93. PubMed ID: 12637119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of memantine on cognition in patients with moderate to severe Alzheimer's disease: post-hoc analyses of ADAS-cog and SIB total and single-item scores from six randomized, double-blind, placebo-controlled studies.
    Mecocci P; Bladström A; Stender K
    Int J Geriatr Psychiatry; 2009 May; 24(5):532-8. PubMed ID: 19274640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donepezil for vascular cognitive impairment.
    Malouf R; Birks J
    Cochrane Database Syst Rev; 2004; (1):CD004395. PubMed ID: 14974068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Memantine for dementia.
    Areosa SA; Sherriff F
    Cochrane Database Syst Rev; 2003; (1):CD003154. PubMed ID: 12535459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Memantine for dementia.
    Areosa SA; Sherriff F; McShane R
    Cochrane Database Syst Rev; 2005 Apr; (2):CD003154. PubMed ID: 15846650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Memantine for dementia.
    Areosa SA; Sherriff F; McShane R
    Cochrane Database Syst Rev; 2005 Jul; (3):CD003154. PubMed ID: 16034889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Memantine treatment in patients with mild to moderate Alzheimer's disease already receiving a cholinesterase inhibitor: a randomized, double-blind, placebo-controlled trial.
    Porsteinsson AP; Grossberg GT; Mintzer J; Olin JT;
    Curr Alzheimer Res; 2008 Feb; 5(1):83-9. PubMed ID: 18288936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Memantine effects measured with the Relevant Outcome Scale for Alzheimer's disease in an open-label, single-arm, multicenter clinical study.
    Holthoff V; Ferris S; Gauthier S; Ihl R; Robert P; Winblad B; Sternberg K; Tennigkeit F;
    Int J Geriatr Psychiatry; 2013 Feb; 28(2):164-72. PubMed ID: 22492589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Memantine for dementia.
    McShane R; Areosa Sastre A; Minakaran N
    Cochrane Database Syst Rev; 2006 Apr; (2):CD003154. PubMed ID: 16625572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of memantine in patients with dementia syndrome. A double-blind, placebo controlled trial.
    Ditzler K
    Arzneimittelforschung; 1991 Aug; 41(8):773-80. PubMed ID: 1781796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of metrifonate on the cognitive, behavioral, and functional performance of Alzheimer's disease patients. Metrifonate Study Group.
    Raskind MA; Cyrus PA; Ruzicka BB; Gulanski BI
    J Clin Psychiatry; 1999 May; 60(5):318-25. PubMed ID: 10362441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABT-126 monotherapy in mild-to-moderate Alzheimer's dementia: randomized double-blind, placebo and active controlled adaptive trial and open-label extension.
    Gault LM; Lenz RA; Ritchie CW; Meier A; Othman AA; Tang Q; Berry S; Pritchett Y; Robieson WZ
    Alzheimers Res Ther; 2016 Oct; 8(1):44. PubMed ID: 27756421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.